Correlation Between Virax Biolabs and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Entero Therapeutics,, you can compare the effects of market volatilities on Virax Biolabs and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Entero Therapeutics,.
Diversification Opportunities for Virax Biolabs and Entero Therapeutics,
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Virax and Entero is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Virax Biolabs and Entero Therapeutics,
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.33 times more return on investment than Entero Therapeutics,. However, Virax Biolabs is 1.33 times more volatile than Entero Therapeutics,. It trades about 0.05 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.04 per unit of risk. If you would invest 210.00 in Virax Biolabs Group on August 27, 2024 and sell it today you would lose (9.00) from holding Virax Biolabs Group or give up 4.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Entero Therapeutics,
Performance |
| Timeline |
| Virax Biolabs Group |
| Entero Therapeutics, |
Virax Biolabs and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Entero Therapeutics,
The main advantage of trading using opposite Virax Biolabs and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
| Entero Therapeutics, vs. Cardinal Health | Entero Therapeutics, vs. Inflection Point Acquisition | Entero Therapeutics, vs. Aquestive Therapeutics | Entero Therapeutics, vs. Mangazeya Mining |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |